These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 2871753)

  • 1. Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. Basis of a new physiologic approach to control of arrhythmia.
    Packer M; Gottlieb SS; Kessler PD
    Am J Med; 1986 Apr; 80(4A):23-9. PubMed ID: 2871753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate and long-term pathophysiologic mechanisms underlying the genesis of sudden cardiac death in patients with congestive heart failure.
    Packer M; Gottlieb SS; Blum MA
    Am J Med; 1987 Mar; 82(3A):4-10. PubMed ID: 2882674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmias and mortality in congestive heart failure.
    Kjekshus J
    Am J Cardiol; 1990 May; 65(19):42I-48I. PubMed ID: 2159694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden cardiac death--an approach to management of the patient at risk.
    Podrid PJ; Blatt CM
    Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why patients with congestive heart failure die: arrhythmias and sudden cardiac death.
    Bigger JT
    Circulation; 1987 May; 75(5 Pt 2):IV28-35. PubMed ID: 3552300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular arrhythmias in congestive heart failure.
    Chakko S; de Marchena E; Kessler KM; Myerburg RJ
    Clin Cardiol; 1989 Sep; 12(9):525-30. PubMed ID: 2571440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of ventricular arrhythmia in chronic congestive heart failure].
    Pulignano G; Giovannini M; Del Sindaco D; Fera MS; Mazza A; Minardi G; Giovannini E
    Clin Ter; 1998; 149(4):297-305. PubMed ID: 9866892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic action of pharmacological administration of magnesium in heart failure: a critical review of new data.
    Sueta CA; Patterson JH; Adams KF
    Magnes Res; 1995 Dec; 8(4):389-401. PubMed ID: 8861138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arrhythmias in chronic heart failure. Prognostic significance and treatment].
    Koenig A; Chauvin M; Thévenin D; Brechenmacher C
    Presse Med; 1991 May; 20(20):950-5. PubMed ID: 1676164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy.
    Chakko CS; Gheorghiade M
    Am Heart J; 1985 Mar; 109(3 Pt 1):497-504. PubMed ID: 3976476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-arrhythmic drug prevention of sudden cardiac death--the status after the CAST study].
    Seipel L; Kühlkamp V
    Z Gesamte Inn Med; 1992 May; 47(5):189-94. PubMed ID: 1615728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure.
    Yamada Y; Kinoshita H; Kuwahara K; Nakagawa Y; Kuwabara Y; Minami T; Yamada C; Shibata J; Nakao K; Cho K; Arai Y; Yasuno S; Nishikimi T; Ueshima K; Kamakura S; Nishida M; Kiyonaka S; Mori Y; Kimura T; Kangawa K; Nakao K
    Cardiovasc Res; 2014 Oct; 104(1):183-93. PubMed ID: 25100767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-arrhythmic therapy and cardiac failure].
    Cosnay P; Babuty D; Charniot JC; Fauchier L; Fauchier JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88 Spec No 5():35-41. PubMed ID: 8729298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arrhythmias and heart failure].
    Amann FW; Candinas R
    Ther Umsch; 1993 Jun; 50(6):419-24. PubMed ID: 8351673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention.
    Das MK; Zipes DP
    J Cardiovasc Pharmacol; 2010 May; 55(5):438-49. PubMed ID: 20509177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches to drug selection and serial drug testing.
    Somberg JC
    J Clin Pharmacol; 1984 Jul; 24(7):320-7. PubMed ID: 6207209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.